Tag: projects

New analytics apps powered by NIQ's Expanded Omnishopper panel bring CPG brands visibility into shopper behavior — supporting cross-sell analysis, loyalty insights, and smarter...

Full Displacement of over 20-year incumbent Approximately 1,000 GPS tracking and house-arrest monitoring units with the opportunity to expandNEW YORK, June 25, 2026 /PRNewswire/...

Project delivered under a US$41 million transaction as part of the 21 MW DC Honeywell portfolio in upstate New York7.01 MW DC ground-mount solar...

First underground core holes intersect a late silver-gold-copper event overprinting the principal polymetallic system, including 0.70 metres (true width) grading 4,604 g/t silver at...

DELRAY BEACH, Fla., June 25, 2026 /PRNewswire/ -- According to MarketsandMarkets, "Polymethyl Methacrylate (PMMA) Market by Grade (General-Purpose, Optical), Form (Extruded Sheet, Cast Acrylic Sheet),...

Delivered 27% reduction in greenhouse gas emissions in Scope 1, 2 (market based) and 3 compared to 2019 base yearAchieved 100% renewable electricity in...

ORLANDO, Fla., June 25, 2026 /PRNewswire/ -- Commissioned in April 2026, the new Water Treatment Plant in Chatham, MA helps the Town meet Massachusetts...

TORONTO, June 25, 2026 /CNW/ - Power Metallic Mines Inc. (the "Company" or "Power Metallic") (TSXV: PNPN) (OTCBB: PNPNF) (Frankfurt: IVV1) is pleased to announce...

Bringing together Elektrobit's software platform and AUTOCRYPT's cybersecurity engineering expertise Advancing software-defined mobility innovation through strategic collaboration SEOUL, South Korea, June 25, 2026 /PRNewswire/ -- AUTOCRYPT, a leading...

CHENGDU, China, June 25, 2026 /PRNewswire/ -- On June 23, 2026, C-Ray Therapeutics (Chengdu) Co., Ltd. ("C-Ray Therapeutics") completed on-site inspections conducted by a panel...

DALLAS, June 24, 2026 (GLOBE NEWSWIRE) -- Taysha Gene Therapies, Inc. (Nasdaq: TSHA) (Taysha or the Company), a clinical-stage biotechnology company focused on advancing adeno-associated virus (AAV)-based gene therapies for severe monogenic diseases of the central nervous system (CNS), today announced the pricing of an underwritten public offering of 32,500,001 shares of its common stock at a price to the public of $6.00 per share and, in lieu of common stock to certain investors that so choose, pre-funded warrants to purchase 833,333 shares of its common stock at an offering price of $5.999 per pre-funded warrant, in each case before underwriting discounts and commissions. All of the securities are being offered by Taysha. In addition, Taysha has granted the underwriters a 30-day option to purchase up to an additional 5,000,000 shares of common stock at the public offering price, less underwriting discounts and commissions. The gross proceeds from the offering to Taysha are expected to be approximately $200.0 million, before deducting underwriting discounts and commissions and other offering expenses, excluding any exercise of the underwriters’ option to purchase additional shares. The offering is expected to close on or about June 26, 2026, subject to customary closing conditions.

MUNICH, June 24, 2026 /PRNewswire/ -- The global clean energy event of the year is here – and cutting-edge technologies are making their way...

PARIS and NEW YORK and LONDON, June 25, 2026 /PRNewswire/ -- AMTD Group Inc. ("AMTD Group"), AMTD IDEA Group ("AMTD IDEA")(NYSE: AMTD; SGX: HKB),...

PARIS and NEW YORK and LONDON, June 24, 2026 /PRNewswire/ -- AMTD Group Inc. ("AMTD Group"), AMTD IDEA Group ("AMTD IDEA")(NYSE: AMTD; SGX: HKB),...